Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-03 Jovan-Embiricos Morana Director Conversion +411,685 411,685
2020-08-03 Jovan-Embiricos Morana Director Purchase +100,000 $17.00 $1.7M 347,011
2020-08-03 Jovan-Embiricos Morana Director Purchase +2,800,000 $17.00 $47.6M 2,800,000
2020-08-03 Jovan-Embiricos Morana Director Conversion · Series A-2 Convertible Preferred Stock −20,000,000 0
2020-08-03 Jovan-Embiricos Morana Director Conversion · Series B Convertible Preferred Stock −368,098 0
2020-08-03 Jovan-Embiricos Morana Director Conversion · Series B Convertible Preferred Stock −2,085,889 0
2020-08-03 Jovan-Embiricos Morana Director Conversion · Series B Convertible Preferred Stock −613,496 0

Page 27 of 27 · 527 trades